No Overview found
No Deliveries found
1 Day |
|
|
1 Week |
|
|
1 Month |
|
|
3 Month |
|
|
6 Month |
|
|
1 Year |
|
|
2 Year |
|
|
5 Year |
|
-61.46% |
10 Year |
|
9 years | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
Return on Equity (%) | -0.01 | -0.01 | -357.96 | 0 | 0 | 0 | 0 | 0 | 0 | |
Return on Capital Employed (%) | -0.01 | 0.07 | -194.26 | 5.08 | -108.57 | -36.29 | -176.12 | -45.82 | -2.08 | |
Return on Assets (%) | -0.01 | 0 | -187.05 | 3.33 | -104.48 | -35.22 | -165.2 | -42.08 | -1.99 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2021-09* Rs. Cr. |
Shh. Funds | 36 | 36 | -10 | -10 | -10 | -11 | -11 | -11 | -11 | -11 | |
Non Curr. Liab. | 11 | 11 | 11 | 10 | 11 | 11 | 11 | 11 | 11 | 11 | |
Curr. Liab. | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Minority Int. | |||||||||||
Equity & Liab. | 48 | 48 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Non Curr. Assets | 48 | 48 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Misc. Exp. not W/O | |||||||||||
Total Assets | 48 | 48 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2021-12 Rs. Cr. TTM |
Net Sales | |||||||||||
Other Income | 0 | 0 | |||||||||
Total Income | 0 | 0 | |||||||||
Total Expenditure | -47 | 0 | 0 | 0 | 0 | 0 | |||||
PBIDT | 0 | -47 | 0 | 0 | 0 | 0 | 0 | ||||
Interest | 0 | 0 | |||||||||
Depreciation | |||||||||||
Taxation | 1 | 0 | |||||||||
Exceptional Items | |||||||||||
PAT | -46 | 0 | 0 | 0 | 0 | 0 | |||||
Adjusted EPS | -23 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
Cash Fr. Operatn. | -2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Cash Fr. Inv. | 5 | 0 | |||||||||
Cash Fr. Finan. | -3 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Net Change | 0 | 0 | 0 | 0 | |||||||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Thu, 17 Feb 2022
Un-Audited Financial Results For The Quarter Ended 31St December 2021 Un-Audited Financial Results for the Quarter ended 31st December 2021 |
Mon, 14 Feb 2022
Board Meeting Outcome for Outcome Of Board Meeting Dated 14Th February 2022 Board Meeting the Board of Directors of the Company has considered and approved the following items along with other items at their meeting held today on February 14 2021: i. Unaudited Financial Results for the quarter and nine months ended December 31 2021; andii. Limited Review Report given by the Statutory Auditor of the Company for the quarter and nine months ended December 31 2021 ; |
Wed, 09 Feb 2022
Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company Will Be Held On Monday 14Thfebruary 2022 At New Delhi. MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve 1. To consider and approve the standalone unaudited financial results for the quarter ended on 31st December 2021 along with Limited Review Reports. 2. Any other business with the permission of the Chairman. |
No Scans Found |